Literature DB >> 13211916

Formation of non-infectious influenza virus in mouse lungs: its dependence upon extensive pulmonary consolidation initiated by the viral inoculum.

H S GINSBERG.   

Abstract

Formation of non-infectious virus-particles which hemagglutinate red blood cells and react with antibody to fix complement but do not infect the chick embryo or mouse-occurred when large quantities of certain strains of influenza viruses were inoculated intranasally into mice. Dependent upon the agent employed, 10(6.5) to 10(8.5) E.I.D. was essential to elicit this phenomenon. To accomplish this unusual multiplication it was essential to use a strain of virus which effected extensive pulmonary consolidation; strains of virus which did not produce marked lung lesions, even when as much as 10(8.5) E.I.D. was inoculated, did not form non-infectious virus. The development of this viral form was directly dependent upon the extent of cell damage obtained: consolidation of more than 50 per cent of the lung volume was required. The majority of non-infectious particles developed during the initial cycle of viral multiplication, and concurrently with the formation of non-infectious virus there was a corresponding decrease in the number of infectious viral particles. Non-infectious virus could not be propagated on serial passage in mouse lungs: on second lung passage only fully infectious virus was detectable. The formation of the non-infectious viral form was not the result of interference with synthesis of infectious virus by inactivated virus in the inoculum; for inoculation of heated infected allantoic fluid which contained more than 99 per cent of non-infectious virus did not result in the development of new non-infectious virus. Although inoculation of a large quantity of virus resulted in infection which yielded a relatively low titer of infectious and high titer of non-infectious virus, inoculation of a small quantity of the agent resulted in a high yield of infectious virus and no non-infectious that was detectable. In both instances the total quantity of antigenic viral material synthesized in the mouse lungs was the same. These data do not support the hypothesis that the non-infectious virus formed consisted of immature or incomplete viral particles, but suggest instead that non-infectious virus is inactivated virus or some aberrant form of the agent.

Entities:  

Keywords:  LUNGS/bacteriology

Mesh:

Substances:

Year:  1954        PMID: 13211916      PMCID: PMC2136397          DOI: 10.1084/jem.100.6.581

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  24 in total

1.  Developmental stages of viruses.

Authors:  R W SCHLESINGER
Journal:  Annu Rev Microbiol       Date:  1953       Impact factor: 15.500

2.  Developmental cycles in animal viruses.

Authors:  W HENLE
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1953

3.  The relation of functionally deficient forms of influenza virus to viral development.

Authors:  R W SCHLESINGER
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1953

4.  Multiplication of influenza virus in the entodermal cells of the allantois of the chick embryo.

Authors:  W HENLE
Journal:  Adv Virus Res       Date:  1953       Impact factor: 9.937

5.  THE AGGLUTINATION OF RED CELLS BY ALLANTOIC FLUID OF CHICK EMBRYOS INFECTED WITH INFLUENZA VIRUS.

Authors:  G K Hirst
Journal:  Science       Date:  1941-07-04       Impact factor: 47.728

6.  Preservation of viruses in a mechanical refrigerator at -25 degrees C.

Authors:  P K OLITSKY; J CASALS
Journal:  J Lab Clin Med       Date:  1949-07

7.  Propagation of the PR8 strain of influenza A virus in chick embryos. IV. Studies on the factors involved in the formation of incomplete virus upon serial passage of undiluted virus.

Authors:  P VON MAGNUS
Journal:  Acta Pathol Microbiol Scand       Date:  1952

8.  The inhibitory effect of polysaccharide on mumps virus multiplication.

Authors:  H S GINSBERG; W F GOEBEL; F L HORSFALL
Journal:  J Exp Med       Date:  1948-05-01       Impact factor: 14.307

9.  THE MOUSE INFECTIVITY TITRATION OF INFLUENZA VIRUS.

Authors:  M A Lauffer; G L Miller
Journal:  J Exp Med       Date:  1944-02-01       Impact factor: 14.307

10.  Multiplication and survival of tubercle bacilli in the organs of mice.

Authors:  C H PIERCE; R J DUBOS; W B SCHAEFER
Journal:  J Exp Med       Date:  1953-02-01       Impact factor: 14.307

View more
  7 in total

1.  [The behavior of influenza viruses in tissue cultures of chick embryo kidneys. II. Virus multiplication].

Authors:  E MANNWEILER
Journal:  Arch Gesamte Virusforsch       Date:  1961

2.  [The behavior of influenza viruses in tissue cultures of chick embryo kidneys. I. Virus adsorption].

Authors:  H LIPPELT; E MANNWEILER
Journal:  Arch Gesamte Virusforsch       Date:  1961

Review 3.  Defective interfering influenza virus RNAs: time to reevaluate their clinical potential as broad-spectrum antivirals?

Authors:  Nigel J Dimmock; Andrew J Easton
Journal:  J Virol       Date:  2014-02-26       Impact factor: 5.103

4.  The nature of the toxic reaction of influenza virus towards lung tissue.

Authors:  S M Barker; L Hoyle
Journal:  J Hyg (Lond)       Date:  1972-09

5.  Reducing uncertainty in within-host parameter estimates of influenza infection by measuring both infectious and total viral load.

Authors:  Stephen M Petrie; Teagan Guarnaccia; Karen L Laurie; Aeron C Hurt; Jodie McVernon; James M McCaw
Journal:  PLoS One       Date:  2013-05-15       Impact factor: 3.240

6.  Influenza virus and its mucoprotein substrate in the chorioallantoic membrane of the chick embryo. II. Stepwise inactivation of substrate and its relation to the mode of viral multiplication.

Authors:  R W SCHLESINGER; H V KARR
Journal:  J Exp Med       Date:  1956-03-01       Impact factor: 14.307

7.  STRUCTURE AND DEVELOPMENT OF VIRUSES AS OBSERVED IN THE ELECTRON MICROSCOPE : VII. INCOMPLETE INFLUENZA VIRUS.

Authors:  C Morgan; K C Hsu; H M Rose
Journal:  J Exp Med       Date:  1962-10-01       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.